We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Below we will list the departments and units that form part of Vall d’Hebron Hospital and the main diseases that we treat. We will also make recommendations based on advice backed up by scientific evidence that has been shown to be effective in guaranteeing well-being and quality of life.
Vols saber com serà la teva estada a l’Hospital Universitari Vall d’Hebron? Aquí trobaràs tota la informació.
Speaker: Dr. Pablo Mir. Movement Disorders Unit, Department of Neurology and Clinical Neurophysiology, Institute of Biomedicine of Seville, Hospital Universitario Virgen del Rocío/University of Seville/CSIC/CIBERNED, Seville, Spain- Biomedical Research Network Center on Neurodegenerative Diseases (CIBERNED), Carlos III Health Institute, Madrid, Spain - Department of Medicine, Faculty of Medicine, University of Seville, Seville, Spain.
Abstract Parkinson’s disease (PD) is one of the most common neurodegenerative disorders, with neuroinflammation playing a significant role in its etiology and progression. Both central and peripheral immune responses are involved, and evidence suggests a brain-periphery interaction in PD. Changes in leukocyte subpopulations have been observed in PD patients, making the neutrophil-to-lymphocyte ratio (NLR) a relevant marker of peripheral inflammation. Patients with PD have a higher NLR compared to healthy controls, indicating increased peripheral inflammation. This higher NLR suggests that the neutrophil-to-lymphocyte ratio is a useful non-invasive biomarker of systemic inflammation in PD. The peripheral immune response differs among patients based on their genetic background, with those having sporadic and GBA-associated PD showing a higher NLR in contrast to those with LRRK2-associated PD. Furthermore, this elevated peripheral inflammation is associated with dopaminergic neurodegeneration, underscoring the importance of understanding inflammatory processes in the context of PD for better diagnostic and therapeutic strategies.
Host: Dr. Ariadna Laguna. Main researcher Neurodegenerative Diseases (VHIR)
Register here to attend by Zoom: https://gencat.zoom.us/j/94801616000
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Hospital Universitari Vall d'Hebron - Institut Català de la Salut. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.